Episode 2June 27, 2026 · 23 min

Atrial Fibrillation

Atrial fibrillation is the most common sustained cardiac arrhythmia and a high-yield topic in medical licensing examinations. In this episode, we review its causes, diagnosis, investigations, and practical management in the family medicine office, with a focus on the Canadian **CHAD-65** approach to stroke prevention and anticoagulation.

Atrial Fibrillation

ATRIAL FIBRILLATION (AF): A HIGH-YIELD REVIEW FOR MEDICAL LICENSING EXAMS

Introduction

Welcome to today's episode. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. It is a frequent presentation in family medicine, emergency medicine, internal medicine, and cardiology, making it one of the highest-yield topics for Canadian medical licensing examinations including TDM, CCFP, and MCCQE1.

Definition

Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterized by chaotic atrial electrical activity resulting in:

  • Absence of organized P waves
  • Irregularly irregular ventricular rhythm
  • Loss of effective atrial contraction
  • Increased risk of thromboembolism and stroke

Causes

Cardiac Causes

  • Hypertension (most common)
  • Coronary artery disease
  • Heart failure
  • Valvular heart disease
  • Cardiomyopathy
  • Myocarditis
  • Congenital heart disease

Non-Cardiac Causes

  • Hyperthyroidism
  • Pulmonary embolism
  • Pneumonia
  • Sepsis
  • Chronic lung disease
  • Obstructive sleep apnea
  • Chronic kidney disease

Reversible Causes

  • Alcohol ("Holiday Heart")
  • Excess caffeine or stimulants
  • Electrolyte abnormalities
  • Recent surgery
  • Acute infection
  • Uncontrolled hypertension

Risk Factors

  • Age ≥65 years
  • Hypertension
  • Diabetes mellitus
  • Heart failure
  • Coronary artery disease
  • Obesity
  • Sleep apnea
  • Chronic kidney disease
  • Smoking
  • Excess alcohol
  • Family history

Clinical Presentation

Many patients are asymptomatic.

Common symptoms include:

  • Palpitations
  • Rapid heartbeat
  • Shortness of breath
  • Fatigue
  • Reduced exercise tolerance
  • Chest discomfort
  • Dizziness
  • Syncope
  • Stroke symptoms

SOAP Approach

Subjective

Ask about:

  • Onset and duration
  • Palpitations
  • Chest pain
  • Dyspnea
  • Dizziness
  • Syncope
  • Previous AF episodes
  • Medication history
  • Alcohol use
  • Thyroid disease
  • Recent illness
  • Stroke or TIA history
  • Bleeding history

Objective

Vital Signs

  • Heart rate
  • Blood pressure
  • Oxygen saturation
  • Temperature

Physical Examination

Cardiovascular

  • Irregularly irregular pulse
  • Tachycardia
  • Murmurs
  • Signs of heart failure

Respiratory

  • Pulmonary edema
  • Infection

Neurological

  • Evidence of stroke

Investigations

Essential

  • 12-lead ECG
  • CBC
  • Electrolytes
  • Creatinine/eGFR
  • TSH
  • Glucose or HbA1c

Additional

  • Troponin if ischemia suspected
  • BNP if heart failure suspected
  • Chest X-ray
  • Echocardiogram
  • Holter monitor if intermittent symptoms

ECG Findings

  • No distinct P waves
  • Irregularly irregular rhythm
  • Variable R-R intervals

Assessment

Determine:

  1. Stable or unstable patient?
  2. New-onset or recurrent AF?
  3. Paroxysmal, persistent, or permanent AF?
  4. Reversible cause present?
  5. Need for anticoagulation using the Canadian CHAD-65 approach.

Management (Canadian Guidelines)

Step 1: Is the Patient Stable?

Unstable Features

  • Hypotension
  • Shock
  • Acute pulmonary edema
  • Ongoing ischemic chest pain
  • Altered mental status
  • Syncope

Management

Immediate referral to the Emergency Department for synchronized electrical cardioversion.

Step 2: Rate Control

Rate control is appropriate for most stable patients.

Metoprolol

  • Start 25–50 mg orally twice daily
  • Titrate gradually
  • Typical maintenance: 50–100 mg twice daily

Bisoprolol

  • 2.5–5 mg orally once daily
  • Maximum: 10 mg daily

Diltiazem (avoid in HFrEF)

  • Extended-release 120–180 mg once daily
  • Maximum: 360 mg daily

Verapamil

  • Extended-release 120–180 mg once daily
  • Maximum: 480 mg daily

Digoxin

Useful mainly in:

  • Heart failure
  • Sedentary patients

Typical maintenance:

  • 0.125 mg daily
  • Lower doses in elderly patients and renal impairment

Step 3: Stroke Prevention (CHAD-65)

The Canadian CHAD-65 approach recommends anticoagulation if:

Age ≥65 years

OR

Any one of:

  • Congestive heart failure
  • Hypertension
  • Diabetes mellitus
  • Previous stroke or TIA

If CHAD-65 positive:

Start anticoagulation unless contraindicated.

Preferred DOACs:

Apixaban

  • 5 mg twice daily
  • Reduce to 2.5 mg twice daily in eligible patients

Rivaroxaban

  • 20 mg once daily with food
  • 15 mg once daily if renal function is reduced

Dabigatran

  • 150 mg twice daily
  • Lower dose may be appropriate in selected patients

Edoxaban

  • 60 mg once daily
  • Dose reduction when indicated

Warfarin

Indications:

  • Mechanical heart valves
  • Moderate or severe rheumatic mitral stenosis

Target INR:

2.0–3.0

Step 4: Rhythm Control

Consider rhythm control if:

  • Significant symptoms
  • Younger patients
  • First episode
  • Heart failure related to AF
  • Patient preference
  • Failure of rate control

Options:

  • Electrical cardioversion
  • Antiarrhythmic drugs
  • Catheter ablation

Lifestyle Management

  • Stop smoking
  • Reduce alcohol intake
  • Weight reduction
  • Regular exercise
  • Control blood pressure
  • Manage diabetes
  • Treat sleep apnea

Follow-Up in Family Medicine

Review within 1–4 weeks:

  • Symptoms
  • Heart rate
  • Blood pressure
  • Medication tolerance
  • Renal function if taking a DOAC

Arrange:

  • Echocardiogram if not already performed
  • Cardiology referral if persistent symptoms, recurrent AF, uncertainty about rhythm control, or consideration of catheter ablation

Complications

  • Ischemic stroke
  • Systemic embolism
  • Heart failure
  • Tachycardia-induced cardiomyopathy
  • Reduced quality of life

Red Flags

Urgent referral if:

  • Hypotension
  • Acute pulmonary edema
  • Chest pain suggestive of myocardial infarction
  • Syncope
  • Acute stroke symptoms
  • Altered mental status

Exam Pearls

  • Always assess whether the patient is stable first.
  • Confirm AF with a 12-lead ECG.
  • Search for reversible causes such as hyperthyroidism, infection, and alcohol use.
  • Use the Canadian CHAD-65 approach to determine the need for anticoagulation.
  • DOACs are preferred for most patients with non-valvular AF.
  • Immediate synchronized cardioversion is indicated for unstable patients.

Take-Home Message

Think systematically:

Recognize AF → Assess stability → Investigate reversible causes → Control the rate or rhythm → Apply CHAD-65 for stroke prevention → Arrange appropriate follow-up and referral when needed.

This content is for educational purposes only and does not constitute medical advice or clinical guidance. Read the full disclaimer.